Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Wenxin Xu, M.D.

Concepts (110)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Wenxin Xu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Wenxin Xu has written about over time.
Antihypertensive Agents, 1 publications between 2015 and 2015, average publication date February 2015. Blood Pressure Determination, 1 publications between 2015 and 2015, average publication date February 2015. Drug Repositioning, 1 publications between 2019 and 2019, average publication date February 2019. Neoplasms, 6 publications between 2007 and 2024, average publication date July 2019. Receptors, Vascular Endothelial Growth Factor, 1 publications between 2019 and 2019, average publication date August 2019. Infection Control, 1 publications between 2021 and 2021, average publication date February 2021. Quarantine, 1 publications between 2021 and 2021, average publication date February 2021. Nephrectomy, 3 publications between 2019 and 2024, average publication date October 2021. Carcinoma, Renal Cell, 12 publications between 2019 and 2024, average publication date January 2022. Kidney Neoplasms, 12 publications between 2019 and 2024, average publication date January 2022. Natural Language Processing, 3 publications between 2020 and 2024, average publication date April 2022. Electronic Health Records, 3 publications between 2020 and 2024, average publication date September 2022. Medical Oncology, 1 publications between 2024 and 2024, average publication date April 2024.

To see the data from this visualization as text, click here.
Xu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (110)
Explore
_
Co-Authors (90)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.